Compile Data Set for Download or QSAR
Report error Found 114 Enz. Inhib. hit(s) with all data for entry = 9098
TargetChymotrypsin-like protease CTRL-1(Human)
Centrax International

US Patent
LigandPNGBDBM441773(US10640533, Table 1.20 | US10640533, Identificatio...)
Affinity DataIC50: 0.920nMAssay Description:Inhibition of the chymotrypsin-like (CT-L), peptidylglutamyl peptide hydrolyzing activity (PGPH), and trypsin-like (T-L) activities of the 20S protea...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/18/2021
Entry Details
Go to US Patent

TargetChymotrypsin-like protease CTRL-1(Human)
Centrax International

US Patent
LigandPNGBDBM441775(US10640533, Table 1.22 | US10640533, Identificatio...)
Affinity DataIC50: 0.970nMAssay Description:Inhibition of the chymotrypsin-like (CT-L), peptidylglutamyl peptide hydrolyzing activity (PGPH), and trypsin-like (T-L) activities of the 20S protea...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/18/2021
Entry Details
Go to US Patent

TargetChymotrypsin-like protease CTRL-1(Human)
Centrax International

US Patent
LigandPNGBDBM441773(US10640533, Table 1.20 | US10640533, Identificatio...)
Affinity DataIC50: 1.09nMAssay Description:Inhibition of the chymotrypsin-like (CT-L), peptidylglutamyl peptide hydrolyzing activity (PGPH), and trypsin-like (T-L) activities of the 20S protea...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/18/2021
Entry Details
Go to US Patent

TargetChymotrypsin-like protease CTRL-1(Human)
Centrax International

US Patent
LigandPNGBDBM441775(US10640533, Table 1.22 | US10640533, Identificatio...)
Affinity DataIC50: 1.34nMAssay Description:Inhibition of the chymotrypsin-like (CT-L), peptidylglutamyl peptide hydrolyzing activity (PGPH), and trypsin-like (T-L) activities of the 20S protea...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/18/2021
Entry Details
Go to US Patent

TargetChymotrypsin-like protease CTRL-1(Human)
Centrax International

US Patent
LigandPNGBDBM441779(US10640533, Table 1.26 | US10640533, Identificatio...)
Affinity DataIC50: 3.58nMAssay Description:Inhibition of the chymotrypsin-like (CT-L), peptidylglutamyl peptide hydrolyzing activity (PGPH), and trypsin-like (T-L) activities of the 20S protea...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/18/2021
Entry Details
Go to US Patent

TargetChymotrypsin-like protease CTRL-1(Human)
Centrax International

US Patent
LigandPNGBDBM441789(US10640533, Table 1.36 | US10640533, Identificatio...)
Affinity DataIC50: 3.73nMAssay Description:Inhibition of the chymotrypsin-like (CT-L), peptidylglutamyl peptide hydrolyzing activity (PGPH), and trypsin-like (T-L) activities of the 20S protea...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/18/2021
Entry Details
Go to US Patent

TargetChymotrypsin-like protease CTRL-1(Human)
Centrax International

US Patent
LigandPNGBDBM441789(US10640533, Table 1.36 | US10640533, Identificatio...)
Affinity DataIC50: 4.26nMAssay Description:Inhibition of the chymotrypsin-like (CT-L), peptidylglutamyl peptide hydrolyzing activity (PGPH), and trypsin-like (T-L) activities of the 20S protea...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/18/2021
Entry Details
Go to US Patent

TargetChymotrypsin-like protease CTRL-1(Human)
Centrax International

US Patent
LigandPNGBDBM441784(US10640533, Table 1.31 | US10640533, Identificatio...)
Affinity DataIC50: 4.28nMAssay Description:Inhibition of the chymotrypsin-like (CT-L), peptidylglutamyl peptide hydrolyzing activity (PGPH), and trypsin-like (T-L) activities of the 20S protea...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/18/2021
Entry Details
Go to US Patent

TargetChymotrypsin-like protease CTRL-1(Human)
Centrax International

US Patent
LigandPNGBDBM441779(US10640533, Table 1.26 | US10640533, Identificatio...)
Affinity DataIC50: 4.65nMAssay Description:Inhibition of the chymotrypsin-like (CT-L), peptidylglutamyl peptide hydrolyzing activity (PGPH), and trypsin-like (T-L) activities of the 20S protea...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/18/2021
Entry Details
Go to US Patent

TargetChymotrypsin-like protease CTRL-1(Human)
Centrax International

US Patent
LigandPNGBDBM441776(US10640533, Table 1.23 | US10640533, Identificatio...)
Affinity DataIC50: 4.74nMAssay Description:Inhibition of the chymotrypsin-like (CT-L), peptidylglutamyl peptide hydrolyzing activity (PGPH), and trypsin-like (T-L) activities of the 20S protea...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/18/2021
Entry Details
Go to US Patent

TargetChymotrypsin-like protease CTRL-1(Human)
Centrax International

US Patent
LigandPNGBDBM441776(US10640533, Table 1.23 | US10640533, Identificatio...)
Affinity DataIC50: 5.10nMAssay Description:Inhibition of the chymotrypsin-like (CT-L), peptidylglutamyl peptide hydrolyzing activity (PGPH), and trypsin-like (T-L) activities of the 20S protea...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/18/2021
Entry Details
Go to US Patent

TargetChymotrypsin-like protease CTRL-1(Human)
Centrax International

US Patent
LigandPNGBDBM441788(US10640533, Table 1.35 | US10640533, Identificatio...)
Affinity DataIC50: 6.10nMAssay Description:Inhibition of the chymotrypsin-like (CT-L), peptidylglutamyl peptide hydrolyzing activity (PGPH), and trypsin-like (T-L) activities of the 20S protea...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/18/2021
Entry Details
Go to US Patent

TargetChymotrypsin-like protease CTRL-1(Human)
Centrax International

US Patent
LigandPNGBDBM441780(US10640533, Table 1.27 | US10640533, Identificatio...)
Affinity DataIC50: 6.56nMAssay Description:Inhibition of the chymotrypsin-like (CT-L), peptidylglutamyl peptide hydrolyzing activity (PGPH), and trypsin-like (T-L) activities of the 20S protea...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/18/2021
Entry Details
Go to US Patent

TargetChymotrypsin-like protease CTRL-1(Human)
Centrax International

US Patent
LigandPNGBDBM441787(US10640533, Table 1.34 | US10640533, Identificatio...)
Affinity DataIC50: 6.81nMAssay Description:Inhibition of the chymotrypsin-like (CT-L), peptidylglutamyl peptide hydrolyzing activity (PGPH), and trypsin-like (T-L) activities of the 20S protea...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/18/2021
Entry Details
Go to US Patent

TargetChymotrypsin-like protease CTRL-1(Human)
Centrax International

US Patent
LigandPNGBDBM441784(US10640533, Table 1.31 | US10640533, Identificatio...)
Affinity DataIC50: 7.41nMAssay Description:Inhibition of the chymotrypsin-like (CT-L), peptidylglutamyl peptide hydrolyzing activity (PGPH), and trypsin-like (T-L) activities of the 20S protea...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/18/2021
Entry Details
Go to US Patent

TargetChymotrypsin-like protease CTRL-1(Human)
Centrax International

US Patent
LigandPNGBDBM441790(US10640533, Table 1.37 | US10640533, Identificatio...)
Affinity DataIC50: 9.75nMAssay Description:Inhibition of the chymotrypsin-like (CT-L), peptidylglutamyl peptide hydrolyzing activity (PGPH), and trypsin-like (T-L) activities of the 20S protea...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/18/2021
Entry Details
Go to US Patent

TargetChymotrypsin-like protease CTRL-1(Human)
Centrax International

US Patent
LigandPNGBDBM441786(US10640533, Table 1.33 | US10640533, Identificatio...)
Affinity DataIC50: 11.1nMAssay Description:Inhibition of the chymotrypsin-like (CT-L), peptidylglutamyl peptide hydrolyzing activity (PGPH), and trypsin-like (T-L) activities of the 20S protea...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/18/2021
Entry Details
Go to US Patent

TargetChymotrypsin-like protease CTRL-1(Human)
Centrax International

US Patent
LigandPNGBDBM441787(US10640533, Table 1.34 | US10640533, Identificatio...)
Affinity DataIC50: 12.2nMAssay Description:Inhibition of the chymotrypsin-like (CT-L), peptidylglutamyl peptide hydrolyzing activity (PGPH), and trypsin-like (T-L) activities of the 20S protea...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/18/2021
Entry Details
Go to US Patent

TargetChymotrypsin-like protease CTRL-1(Human)
Centrax International

US Patent
LigandPNGBDBM441781(US10640533, Table 1.28 | US10640533, Identificatio...)
Affinity DataIC50: 13.5nMAssay Description:Inhibition of the chymotrypsin-like (CT-L), peptidylglutamyl peptide hydrolyzing activity (PGPH), and trypsin-like (T-L) activities of the 20S protea...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/18/2021
Entry Details
Go to US Patent

TargetChymotrypsin-like protease CTRL-1(Human)
Centrax International

US Patent
LigandPNGBDBM441786(US10640533, Table 1.33 | US10640533, Identificatio...)
Affinity DataIC50: 14.2nMAssay Description:Inhibition of the chymotrypsin-like (CT-L), peptidylglutamyl peptide hydrolyzing activity (PGPH), and trypsin-like (T-L) activities of the 20S protea...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/18/2021
Entry Details
Go to US Patent

TargetChymotrypsin-like protease CTRL-1(Human)
Centrax International

US Patent
LigandPNGBDBM441790(US10640533, Table 1.37 | US10640533, Identificatio...)
Affinity DataIC50: 15.3nMAssay Description:Inhibition of the chymotrypsin-like (CT-L), peptidylglutamyl peptide hydrolyzing activity (PGPH), and trypsin-like (T-L) activities of the 20S protea...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/18/2021
Entry Details
Go to US Patent

TargetChymotrypsin-like protease CTRL-1(Human)
Centrax International

US Patent
LigandPNGBDBM441785(US10640533, Table 1.32 | US10640533, Identificatio...)
Affinity DataIC50: 16nMAssay Description:Inhibition of the chymotrypsin-like (CT-L), peptidylglutamyl peptide hydrolyzing activity (PGPH), and trypsin-like (T-L) activities of the 20S protea...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/18/2021
Entry Details
Go to US Patent

TargetChymotrypsin-like protease CTRL-1(Human)
Centrax International

US Patent
LigandPNGBDBM441780(US10640533, Table 1.27 | US10640533, Identificatio...)
Affinity DataIC50: 28.1nMAssay Description:Inhibition of the chymotrypsin-like (CT-L), peptidylglutamyl peptide hydrolyzing activity (PGPH), and trypsin-like (T-L) activities of the 20S protea...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/18/2021
Entry Details
Go to US Patent

TargetChymotrypsin-like protease CTRL-1(Human)
Centrax International

US Patent
LigandPNGBDBM441785(US10640533, Table 1.32 | US10640533, Identificatio...)
Affinity DataIC50: 31.7nMAssay Description:Inhibition of the chymotrypsin-like (CT-L), peptidylglutamyl peptide hydrolyzing activity (PGPH), and trypsin-like (T-L) activities of the 20S protea...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/18/2021
Entry Details
Go to US Patent

TargetChymotrypsin-like protease CTRL-1(Human)
Centrax International

US Patent
LigandPNGBDBM441774(US10640533, Table 1.21 | US10640533, Identificatio...)
Affinity DataIC50: 33.3nMAssay Description:Inhibition of the chymotrypsin-like (CT-L), peptidylglutamyl peptide hydrolyzing activity (PGPH), and trypsin-like (T-L) activities of the 20S protea...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/18/2021
Entry Details
Go to US Patent

TargetChymotrypsin-like protease CTRL-1(Human)
Centrax International

US Patent
LigandPNGBDBM441774(US10640533, Table 1.21 | US10640533, Identificatio...)
Affinity DataIC50: 33.6nMAssay Description:Inhibition of the chymotrypsin-like (CT-L), peptidylglutamyl peptide hydrolyzing activity (PGPH), and trypsin-like (T-L) activities of the 20S protea...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/18/2021
Entry Details
Go to US Patent

TargetChymotrypsin-like protease CTRL-1(Human)
Centrax International

US Patent
LigandPNGBDBM441788(US10640533, Table 1.35 | US10640533, Identificatio...)
Affinity DataIC50: 59.3nMAssay Description:Inhibition of the chymotrypsin-like (CT-L), peptidylglutamyl peptide hydrolyzing activity (PGPH), and trypsin-like (T-L) activities of the 20S protea...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/18/2021
Entry Details
Go to US Patent

TargetChymotrypsin-like protease CTRL-1(Human)
Centrax International

US Patent
LigandPNGBDBM441781(US10640533, Table 1.28 | US10640533, Identificatio...)
Affinity DataIC50: 60.4nMAssay Description:Inhibition of the chymotrypsin-like (CT-L), peptidylglutamyl peptide hydrolyzing activity (PGPH), and trypsin-like (T-L) activities of the 20S protea...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/18/2021
Entry Details
Go to US Patent

TargetChymotrypsin-like protease CTRL-1(Human)
Centrax International

US Patent
LigandPNGBDBM441778(US10640533, Table 1.25 | US10640533, Identificatio...)
Affinity DataIC50: 62.4nMAssay Description:Inhibition of the chymotrypsin-like (CT-L), peptidylglutamyl peptide hydrolyzing activity (PGPH), and trypsin-like (T-L) activities of the 20S protea...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/18/2021
Entry Details
Go to US Patent

TargetChymotrypsin-like protease CTRL-1(Human)
Centrax International

US Patent
LigandPNGBDBM441783(US10640533, Table 1.30 | US10640533, Identificatio...)
Affinity DataIC50: 113nMAssay Description:Inhibition of the chymotrypsin-like (CT-L), peptidylglutamyl peptide hydrolyzing activity (PGPH), and trypsin-like (T-L) activities of the 20S protea...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/18/2021
Entry Details
Go to US Patent

TargetChymotrypsin-like protease CTRL-1(Human)
Centrax International

US Patent
LigandPNGBDBM441782(US10640533, Table 1.29 | US10640533, Identificatio...)
Affinity DataIC50: 121nMAssay Description:Inhibition of the chymotrypsin-like (CT-L), peptidylglutamyl peptide hydrolyzing activity (PGPH), and trypsin-like (T-L) activities of the 20S protea...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/18/2021
Entry Details
Go to US Patent

TargetChymotrypsin-like protease CTRL-1(Human)
Centrax International

US Patent
LigandPNGBDBM50398607(ONX 0912 | OPROZOMIB | US10640533, Identification ...)
Affinity DataIC50: 124nMAssay Description:Inhibition of the chymotrypsin-like (CT-L), peptidylglutamyl peptide hydrolyzing activity (PGPH), and trypsin-like (T-L) activities of the 20S protea...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/18/2021
Entry Details
Go to US Patent

TargetChymotrypsin-like protease CTRL-1(Human)
Centrax International

US Patent
LigandPNGBDBM441782(US10640533, Table 1.29 | US10640533, Identificatio...)
Affinity DataIC50: 170nMAssay Description:Inhibition of the chymotrypsin-like (CT-L), peptidylglutamyl peptide hydrolyzing activity (PGPH), and trypsin-like (T-L) activities of the 20S protea...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/18/2021
Entry Details
Go to US Patent

TargetTransmembrane protease serine 11D(Human)
Centrax International

US Patent
LigandPNGBDBM441788(US10640533, Table 1.35 | US10640533, Identificatio...)
Affinity DataIC50: 186nMAssay Description:Inhibition of the chymotrypsin-like (CT-L), peptidylglutamyl peptide hydrolyzing activity (PGPH), and trypsin-like (T-L) activities of the 20S protea...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/18/2021
Entry Details
Go to US Patent

TargetChymotrypsin-like protease CTRL-1(Human)
Centrax International

US Patent
LigandPNGBDBM441778(US10640533, Table 1.25 | US10640533, Identificatio...)
Affinity DataIC50: 248nMAssay Description:Inhibition of the chymotrypsin-like (CT-L), peptidylglutamyl peptide hydrolyzing activity (PGPH), and trypsin-like (T-L) activities of the 20S protea...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/18/2021
Entry Details
Go to US Patent

TargetChymotrypsin-like protease CTRL-1(Human)
Centrax International

US Patent
LigandPNGBDBM50398607(ONX 0912 | OPROZOMIB | US10640533, Identification ...)
Affinity DataIC50: 256nMAssay Description:Inhibition of the chymotrypsin-like (CT-L), peptidylglutamyl peptide hydrolyzing activity (PGPH), and trypsin-like (T-L) activities of the 20S protea...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/18/2021
Entry Details
Go to US Patent

TargetTransmembrane protease serine 11D(Human)
Centrax International

US Patent
LigandPNGBDBM441788(US10640533, Table 1.35 | US10640533, Identificatio...)
Affinity DataIC50: 297nMAssay Description:Inhibition of the chymotrypsin-like (CT-L), peptidylglutamyl peptide hydrolyzing activity (PGPH), and trypsin-like (T-L) activities of the 20S protea...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/18/2021
Entry Details
Go to US Patent

TargetChymotrypsin-like protease CTRL-1(Human)
Centrax International

US Patent
LigandPNGBDBM441783(US10640533, Table 1.30 | US10640533, Identificatio...)
Affinity DataIC50: 392nMAssay Description:Inhibition of the chymotrypsin-like (CT-L), peptidylglutamyl peptide hydrolyzing activity (PGPH), and trypsin-like (T-L) activities of the 20S protea...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/18/2021
Entry Details
Go to US Patent

TargetTransmembrane protease serine 11D(Human)
Centrax International

US Patent
LigandPNGBDBM441779(US10640533, Table 1.26 | US10640533, Identificatio...)
Affinity DataIC50: 443nMAssay Description:Inhibition of the chymotrypsin-like (CT-L), peptidylglutamyl peptide hydrolyzing activity (PGPH), and trypsin-like (T-L) activities of the 20S protea...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/18/2021
Entry Details
Go to US Patent

TargetTransmembrane protease serine 11D(Human)
Centrax International

US Patent
LigandPNGBDBM441779(US10640533, Table 1.26 | US10640533, Identificatio...)
Affinity DataIC50: 455nMAssay Description:Inhibition of the chymotrypsin-like (CT-L), peptidylglutamyl peptide hydrolyzing activity (PGPH), and trypsin-like (T-L) activities of the 20S protea...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/18/2021
Entry Details
Go to US Patent

TargetTransmembrane protease serine 11D(Human)
Centrax International

US Patent
LigandPNGBDBM441789(US10640533, Table 1.36 | US10640533, Identificatio...)
Affinity DataIC50: 490nMAssay Description:Inhibition of the chymotrypsin-like (CT-L), peptidylglutamyl peptide hydrolyzing activity (PGPH), and trypsin-like (T-L) activities of the 20S protea...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/18/2021
Entry Details
Go to US Patent

TargetChymotrypsin-like protease CTRL-1(Human)
Centrax International

US Patent
LigandPNGBDBM441777(US10640533, Table 1.24 | US10640533, Identificatio...)
Affinity DataIC50: 500nMAssay Description:Inhibition of the chymotrypsin-like (CT-L), peptidylglutamyl peptide hydrolyzing activity (PGPH), and trypsin-like (T-L) activities of the 20S protea...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/18/2021
Entry Details
Go to US Patent

TargetChymotrypsin-like protease CTRL-1(Human)
Centrax International

US Patent
LigandPNGBDBM441777(US10640533, Table 1.24 | US10640533, Identificatio...)
Affinity DataIC50: 500nMAssay Description:Inhibition of the chymotrypsin-like (CT-L), peptidylglutamyl peptide hydrolyzing activity (PGPH), and trypsin-like (T-L) activities of the 20S protea...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/18/2021
Entry Details
Go to US Patent

TargetTransmembrane protease serine 11D(Human)
Centrax International

US Patent
LigandPNGBDBM441789(US10640533, Table 1.36 | US10640533, Identificatio...)
Affinity DataIC50: 542nMAssay Description:Inhibition of the chymotrypsin-like (CT-L), peptidylglutamyl peptide hydrolyzing activity (PGPH), and trypsin-like (T-L) activities of the 20S protea...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/18/2021
Entry Details
Go to US Patent

TargetTransmembrane protease serine 11D(Human)
Centrax International

US Patent
LigandPNGBDBM441778(US10640533, Table 1.25 | US10640533, Identificatio...)
Affinity DataIC50: 1.65E+3nMAssay Description:Inhibition of the chymotrypsin-like (CT-L), peptidylglutamyl peptide hydrolyzing activity (PGPH), and trypsin-like (T-L) activities of the 20S protea...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/18/2021
Entry Details
Go to US Patent

TargetTransmembrane protease serine 11D(Human)
Centrax International

US Patent
LigandPNGBDBM441778(US10640533, Table 1.25 | US10640533, Identificatio...)
Affinity DataIC50: 3.60E+3nMAssay Description:Inhibition of the chymotrypsin-like (CT-L), peptidylglutamyl peptide hydrolyzing activity (PGPH), and trypsin-like (T-L) activities of the 20S protea...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/18/2021
Entry Details
Go to US Patent

TargetTransmembrane protease serine 11D(Human)
Centrax International

US Patent
LigandPNGBDBM441781(US10640533, Table 1.28 | US10640533, Identificatio...)
Affinity DataIC50: 5.86E+3nMAssay Description:Inhibition of the chymotrypsin-like (CT-L), peptidylglutamyl peptide hydrolyzing activity (PGPH), and trypsin-like (T-L) activities of the 20S protea...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/18/2021
Entry Details
Go to US Patent

TargetTransmembrane protease serine 11D(Human)
Centrax International

US Patent
LigandPNGBDBM441776(US10640533, Table 1.23 | US10640533, Identificatio...)
Affinity DataIC50: 6.23E+3nMAssay Description:Inhibition of the chymotrypsin-like (CT-L), peptidylglutamyl peptide hydrolyzing activity (PGPH), and trypsin-like (T-L) activities of the 20S protea...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/18/2021
Entry Details
Go to US Patent

TargetTransmembrane protease serine 11D(Human)
Centrax International

US Patent
LigandPNGBDBM441780(US10640533, Table 1.27 | US10640533, Identificatio...)
Affinity DataIC50: 6.45E+3nMAssay Description:Inhibition of the chymotrypsin-like (CT-L), peptidylglutamyl peptide hydrolyzing activity (PGPH), and trypsin-like (T-L) activities of the 20S protea...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/18/2021
Entry Details
Go to US Patent

TargetTransmembrane protease serine 11D(Human)
Centrax International

US Patent
LigandPNGBDBM441776(US10640533, Table 1.23 | US10640533, Identificatio...)
Affinity DataIC50: 9.95E+3nMAssay Description:Inhibition of the chymotrypsin-like (CT-L), peptidylglutamyl peptide hydrolyzing activity (PGPH), and trypsin-like (T-L) activities of the 20S protea...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/18/2021
Entry Details
Go to US Patent

Displayed 1 to 50 (of 114 total ) | Next | Last >>
Jump to: